rs12523441
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_198321.4(GALNT10):c.160-19709C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.364 in 152,166 control chromosomes in the GnomAD database, including 12,098 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.36 ( 12098 hom., cov: 33)
Consequence
GALNT10
NM_198321.4 intron
NM_198321.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.182
Publications
4 publications found
Genes affected
GALNT10 (HGNC:19873): (polypeptide N-acetylgalactosaminyltransferase 10) This gene encodes a member of the GalNAc polypeptide N-acetylgalactosaminyltransferases. These enzymes catalyze the first step in the synthesis of mucin-type oligosaccharides. These proteins transfer GalNAc from UDP-GalNAc to either serine or threonine residues of polypeptide acceptors. The protein encoded by this locus may have increased catalytic activity toward glycosylated peptides compared to activity toward non-glycosylated peptides.[provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.742 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.364 AC: 55354AN: 152048Hom.: 12080 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
55354
AN:
152048
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.364 AC: 55401AN: 152166Hom.: 12098 Cov.: 33 AF XY: 0.370 AC XY: 27553AN XY: 74394 show subpopulations
GnomAD4 genome
AF:
AC:
55401
AN:
152166
Hom.:
Cov.:
33
AF XY:
AC XY:
27553
AN XY:
74394
show subpopulations
African (AFR)
AF:
AC:
5531
AN:
41528
American (AMR)
AF:
AC:
8578
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
1568
AN:
3472
East Asian (EAS)
AF:
AC:
3942
AN:
5174
South Asian (SAS)
AF:
AC:
2143
AN:
4826
European-Finnish (FIN)
AF:
AC:
4166
AN:
10564
Middle Eastern (MID)
AF:
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28233
AN:
67994
Other (OTH)
AF:
AC:
829
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1638
3277
4915
6554
8192
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
532
1064
1596
2128
2660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1957
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.